The Orthobiologics Market in North America is Estimated to Grow to Around $4796.3 Million by 2018 - New Report by MicroMarket Monitor
(PRWEB) September 29, 2014 -- The orthobiologics market in North America is estimated to grow to around $4796.3 million by 2018, at a developing CAGR of 7.2% from 2013 to 2018.
Browse through the TOC of the North American orthobiologics market, to get an idea of the in-depth analysis provided. This also provides glimpse of orthobiologics market segmentation in the same region, and is supported by various tables and figures.
http://www.micromarketmonitor.com/market/north-america-orthobiologics-9077664565.html
The major factors for the growth of orthopedics market in North America are reimbursement policies for orthopedic treatment, increased affordability, and higher adoption of upcoming technologies such as MIS and orthobiologics solution.
The population aging is high in North America and 14% of the total North American population is above 65 years of age. The number of the older population is expected to increase manifold in future. They are prone to osteoarthritis and bone fracture and require orthopedic treatments and implants on a large scale. Moreover, increase in obesity rate coupled with rise in demand for minimally invasive procedures has created a considerable demand for bone graft substitutes. In addition, technological advancements, growing patient awareness, rising incidences of road accidents and sport injuries has augmented the growth of this market.
Speak to Analyst @
http://www.micromarketmonitor.com/contact/9077664565-speak_to_analyst.html
The U.S. contributes largely to the orthobiologics market in North America, with around 92% alone, in 2014. In addition to rising number of aging population, U.S. also has highest incidence rates of osteoporosis, which is one of the causes of bone fracture among st the elderly.
This market is segmented and forecast on the basis of various types of products, namely, bone allograft, bone graft substitutes, bone growth factors & spinal stimulation, stem cell therapy, and visco supplementation. The market is further segmented and forecast on the basis of major countries, such as the U.S., Canada and Mexico. The market is also segmented and analyzed further on the basis of the end users.
Early buyers will receive 10% customization on this report.
http://www.micromarketmonitor.com/contact/9077664565-request_for_customization.html
This report also includes the market share, value chain analyses, and market metrics such as drivers, restraints and upcoming opportunities in the market. In addition, it presents a competitive landscape and company profiles of key players in the market.
Related Reports:
European Orthobiologics Market
Orthobiologics are substances that orthopedic surgeons use to help injuries heal more quickly. They are
used to improve the healing of broken bones and injured muscles, tendons, and ligaments. These products are made from substances that are naturally found in human body.
The European Orthobiologics Market is mainly driven by innovation in implant technologies and shifting demand from mechanical to biological solutions. The report “European Orthobiologics Market forecast, 2012-2018” analyzes the market of Orthobiologics industry by 6 product segments such as Bone Allograft, Bone Graft Substitutes, Bone Growth Factors & Spinal Stimulation, Stem Cell Therapy and Visco-supplementation.
All of these segments experienced a positive growth from 2012 with an increased demand for technological advances in bone graft materials. The markets have been witnessing the maximum growth because of demand for innovative products and rising prevalence of chronic arthritis and rapidly aging world population.
http://www.micromarketmonitor.com/market/europe-orthobiologics-9908210168.html
Asian Orthobiologics Market
Orthobiologics are substances that orthopedic surgeons use to help injuries heal more quickly. They are used to improve the healing of broken bones and injured muscles, tendons, and ligaments. These products are made from substances that are naturally found in human body.
The Asian Orthobiologics Market is mainly driven by innovation in implant technologies and shifting demand from mechanical to biological solutions. The report “Asian Orthobiologics Market forecast, 2012-2018” analyzes the market of Orthobiologics industry by 6 product segments such as Bone Allograft, Bone Graft Substitutes, Bone Growth Factors & Spinal Stimulation, Stem Cell Therapy and Visco-supplementation.
All of these segments experienced a positive growth from 2012 with an increased demand for technological advances in bone graft materials. The markets have been witnessing the maximum growth because of demand for innovative products and rising prevalence of chronic arthritis and rapidly aging world population.
http://www.micromarketmonitor.com/market/asia-orthobiologics-7943449547.html
About MicroMarket Monitor:
MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.
Contact:
Mr. Chandrasekhar K.
5601 Bridge Street
Suite 300
Fort Worth, TX 76112
Tel: +1-888-502-0539
Email: sales(at)micromarketmonitor(dot)com
Connect with us on LinkedIn at http://www.linkedin.com/company/micromarketmonitor.
Mr. Chandrasekhar K., MicroMarket Monitor, http://www.micromarketmonitor.com/, +91 9881155004, [email protected]
Share this article